Project Grant HT94252510323
Award Date
5/1/25
Completion Date
4/30/28
Dollars Obligated
$910K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
The Geneva Foundation received a $453,029 Project Grant award from the Department of the Army Medical Command on February 1, 2021 to improve the therapeutic index of antibody drug conjugates targeting metastatic breast cancer. Funded through January 31, 2024 under the Military Medical Research and Development program (CFDA 12.420), this award will support the Foundation's work to transform healthcare and investigate medical solutions for the battlefield by developing more effective targeted...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Geneva Foundation was awarded a $362,100 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research toward the dual targeting of HER2 and androgen receptor in patients with high-risk, hormone-naive prostate cancer with curative intent. The two-year grant project period runs from June 1, 2022 to May 31, 2024. Through this funding, The Geneva Foundation will perform applied medical research investigating...
This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
The Geneva Foundation was awarded a $1,054,546 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will support research into the role of U2AF1 mutations in myelodysplastic syndrome and their potential role as a noncanonical splicing factor in bone marrow failure. Through July 2025, the Geneva Foundation will investigate how these genetic mutations impact splicing and the development of...
The Department of the Army Medical Command awarded a $293,301 Project Grant to The Geneva Foundation for the period of August 1, 2022 through July 31, 2025. The grant supports research titled "MACHINE LEARNING-BASED INTEGRATED MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF ADVANCED PROSTATE CANCER" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health care through innovative biomedical research that...
The U.S. Department of Defense's Defense Health Agency awarded a $488,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization. The grant, awarded on July 1, 2024, supports research to investigate novel mechanisms of regulating the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma, a type of soft tissue cancer. The research aims to advance treatments for this rare and aggressive form of cancer, with a projected...
The Geneva Foundation will receive $910,559 under a Cooperative Agreement awarded by the Department of the Army Medical Command on August 15, 2022. The funding supports a research project titled "In Vivo Imaging of Lymphatic Circulation: Measurement of Brain Interstitial Fluid Flow During Wake and Sleep with Ultra-High Performance MRI." The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research, as part of...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
The Department of the Army Medical Command awarded a $464,591 Project Grant to The Geneva Foundation to support lipidomics and metabolomic profiling research related to pancreatic cancer risk among Women's Health Initiative study participants. The three-year award, issued on September 15, 2022 and running through September 14, 2025, will fund research under the Military Medical Research and Development program. This program aims to transform military and public health through innovative...